Last updated on February 2019

An Induction Study of Mirikizumab in Participants With Moderately to Severely Active Ulcerative Colitis (LUCENT 1)


Brief description of study

The purpose of this study is to evaluate the safety and efficacy of Mirikizumab in participants with moderately to severely active ulcerative colitis (UC) who have had an inadequate response to, loss of response, or intolerant to conventional or biologic therapy for UC.

Clinical Study Identifier: NCT03518086

Contact Investigators or Research Sites near you

Start Over

Raja miroshnichenko

Pusat Perubatan University Kebangsaan Malaysia
Cheras, Kuala Lumpur, Malaysia
3.86miles
  Connect »

Rosaida Hj Md Said

Hospital Ampang
Ampang, Malaysia
5.13miles
  Connect »

Ida Normiha Hilmi

University Malaya Medical Centre
Lembah Pantai, Malaysia
7.0miles
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.